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Abstract
Background: Hospitalization for older patients with community-acquired pneumonia (CAP) is associated
with functional decline. Little is know about the relationship between inflammatory markers and
determinants of functional status in this population. The aim of the study is to investigate the association
between tumor necrosis factor (TNF)-α, C-reactive protein (CRP) and Activities of Daily Living, and to
identify risk factors associated with one year mortality or hospital readmission.
Methods: 301 consecutive patients hospitalized for CAP (mean age 73.9 ± 5.3 years) in a University
affiliated hospital over 18 month period were included. All patients were evaluated on admission to identify
baseline demographic, microbiological, cognitive and functional characteristics. Serum levels for TNF-α
and CRP were collected at the same time. Reassessment of functional status at discharge, and monthly
thereafter till 3 months post discharge was obtained and compared with preadmission level to document
loss or recovery of functionality. Outcome was assessed by the composite endpoint of hospital
readmission or death from any cause up to one year post hospital discharge.
Results: 36% of patients developed functional decline at discharge and 11% had persistent functional
impairment at 3 months. Serum TNF-α (odds ratio [OR] 1.12, 95% CI 1.08–1.15; p < 0.001) and the
Charlson Index (OR = 1.39, 95% CI 1.14 to 1.71; p = 0.001) but not age, CRP, or cognitive status were
independently associated with loss of functionality at the time of hospital discharge. Lack of recovery in
functional status at 3 months was associated with impaired cognitive ability and preadmission
comorbidities. In Cox regression analysis, persistent functional impairment at 3 months, impaired cognitive
function, and the Charlson Index were highly predictive of one year hospital readmission or death.
Conclusion: Serum TNF-α levels can be useful in determining patients at risk for functional impairment
following hospitalization from CAP. Old patients with impaired cognitive function and preexisting
comorbidities who exhibit delay in functional recovery at 3 months post discharge may be at high risk for
hospital readmission and death. With the scarcity of resources, a future risk stratification system based on
these findings might be proven helpful to target older patients who are likely to benefit from interventional
strategies.
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Background
Pneumonia is one of the most common and significant
health problems in the elderly. Together with influenza, it
remains the eighth-leading cause in the United States and
the leading infectious cause of death in this age group [1].
Approximately 366,000 elderly persons are discharged
annually from short-stay hospitals after treatment for
community-acquired pneumonia (CAP) [2] at a cost that
exceeds $4.4 billion [3]. According to a recent analysis of
the National Hospital Discharge Survey, the rates of hos-
pitalization from pneumonia in this population have
increased by 20 percent from 1988–1990 to 2000–2002
for patients aged 65 to 84 years old [4].
For elderly patients, hospitalization following an acute ill-
ness may lead to permanent functional declines or at
times, even death [5]. Twenty five to 60% of older patients
experience a loss of independent physical function while
being treated in the hospital [6]. Recovery is usually pro-
longed especially in the frail elderly who may require up
to several weeks to return to their baseline functional sta-
tus. Cross sectional studies have identified significant
association between increased inflammatory markers and
functional disability [7,8]. Circulating levels of pro-
inflammatory cytokines, such as interleukin (IL)-6 and
tumor necrosis factor (TNF)-α, are usually elevated in CAP
[9] while C-reactive protein (CRP) may correlate with
severity [10]. However, the relationship of pro-inflamma-
tory biomarkers to functional decline in older patients fol-
lowing an acute illness is unclear. After the
implementation of a CAP clinical pathway, we conducted
a prospective observational study to investigate the fol-
lowing aims: 1) to investigate the association between lev-
els of TNF-α and CRP on admission and decrease in
activities of daily living at the time of hospital discharge,
2) to determine the extent to which patients with various
mortality risks recover to preadmission level of activities
of daily living during the first 90 days after discharge, and
3) to identify risk factors associated with one year mortal-
ity or hospital readmission.
Methods
Study population
Between January 2003 and June 2004, all elderly patients
(age ≥ 65 years old) admitted to a University-affiliated
hospital with the diagnosis of CAP were considered for
enrollment. Community-acquired pneumonia was
defined according to the following criteria: 1) the pres-
ence of a new pulmonary infiltrate on the chest radio-
graph; 2) the new onset of at least two of the following
symptoms: cough, dyspnea, chest pain, change in mental
status; 3) temperature ≥38°C or ≤36.0°C, and/or leukocy-
tosis (>11.0 × 109/L) or neutropenia (3.5 × 109/L); and 4)
the absence of evidence of a cause other than pneumonia.
Patients residing in nursing homes or who were hospital-
ized in the last 90 days were not included. Patients with
aspiration, severe immunosuppression (solid organ trans-
plantation, steroid therapy ≥10 mg/d for more than 2
weeks, known Human Immunodeficiency Virus, or
Acquired Immunodeficiency Syndrome defining criteria),
underlying active malignancy, or who had a Do-Not
Resuscitate order (DNR) were also excluded. The Institu-
tional Review Board for human studies approved the
study. Participants or their family members gave informed
consent at the time of enrollment.
Pneumonia pathway
An admission pneumonia pathway was developed by the
hospital committee for quality improvement for the man-
agement of CAP. The pathway included preprinted orders
that included assessment of oxygen saturation, collection
of two sets of blood cultures, choice of antimicrobial ther-
apy between a third generation cephalosporin plus a mac-
rolide or a fluoroquinolone intravenously, and
administration of pneumococcal and influenza vaccines if
no contraindication exists. Counseling in the form of lit-
erature review or a video taped seminar regarding smok-
ing cessation was provided during hospital admission.
Once clinical stability was achieved (defined as heart rate
≤100 beat/min, systolic blood pressure ≥90 mmHg, oral
temperature ≤37.5°C for 24 hour, and return of oxygen
saturation to baseline at ≥90%) [11], an assessment of
safe discharge was determined based on functional status
and social support.
Data collection
Enrolled patients were assessed by a member of the
research team within 24 hours of hospital admission.
Records were examined carefully and data on demo-
graphic information, and clinical presentation was gath-
ered. The Pneumonia Severity Index (PSI) score [12] and
the Charlson Comorbidity Index [13] were obtained at
the time of admission. Patients or their next of kin were
asked to report on their ability to perform six activities of
daily living (bathing, dressing, transferring, walking, toi-
leting, and eating) two weeks prior to admission. For each
area of activity, patients were assigned a score of ranging
from 1 if they were fully independent to 3 if they were
completely dependent. An Activity of Daily Living (ADL)
score [14] was generated. An abbreviated Mini-Mental
State Examination (MMSE) was also obtained during the
admission interview [15]. The abbreviated MMSE omits
the language items of the test: naming, repetition, three-
stage command, reading, writing, and copying because of
concern about the ability of acutely ill elderly patients to
complete these tasks.
All chest roentgenograms were evaluated independently
by two pulmonologists (AES and LP). Differences among
the two examiners were resolved by consensus. Data onBMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
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antimicrobial coverage, time to administration, and total
duration were recorded.
Microbiology
Regular sampling was done of sputum, blood cultures and
serum for serology. Sputum was Gram stained. Represent-
ative sputum originating from the lower respiratory tract
was defined as that containing > 25 granulocytes and < 10
epithelial cells per low power field (total magnification ×
100) [16]. Sputum and pleural fluid were cultured in the
following medium: 5% sheep's blood, chocolate agar, and
MacConkey plates. The etiology of pneumonia was con-
sidered as definitive under the following conditions: 1)
isolation of a pathogen in cultures of blood or pleural
fluid; 2) increase of IgM titers for Chlamydia pneumoniae
(IgM > 1:32), Coxiella burnetii (IgM > 1:80), Mycoplasma
pneumoniae (any positive titer); 3) positive direct fluores-
cent antibody for influenza virus; 4) a single titer (IgG
>1:128) or a positive urinary antigen for Legionella pneu-
mophila; or 5) a positive urinary antigen for Streptococcus
pneumoniae [17,18]. Valid samples of sputum growing a
predominant microorganism were considered for a prob-
able bacteriological diagnosis [17].
Outcome
We defined a decline in functional status a priori as a 2-
point increase on the ADL scale. Conversely, a 2-point
decrease on the ADL scale was interpreted as an improve-
ment in functional status. All patients received a standard
follow up call at 30, 60, and 90 days after discharge to
ascertain functional status recovery. All follow up inter-
views were conducted by the same personnel. Outcome
was assessed by the composite endpoint of hospital
readmission or death from any cause up to one year post
hospital discharge. An unfavorable outcome was defined
as hospital readmission or death. Vital records from the
New York Department of Public Health (regarding in-
state deaths) and the Social Security Administration
Death Master File [19,20] (regarding out-of-state deaths)
were used to determine or confirm death at one year post
discharge. Readmissions were determined from partici-
pants, family reports, or medical records.
Systemic markers of inflammation
Venous blood samples were collected from all partici-
pants at the time of admission to the general wards. Spec-
imens were placed immediately on ice and rapidly
transferred to the laboratory to be centrifuged and stored
at -70°C. Assays for CRP and TNF-α levels were performed
in a single batch by one of the authors who was blinded
to the clinical details of individual patients. Plasma TNF-
α levels were measured in duplicate using enzyme-linked
immunosorbent assay (ELISA) kits (R & D Systems, Min-
neapolis, MN). The detectable limit for TNF-α was 0.18
pg/mL. Plasma levels of CRP were also measured in dupli-
cate using ELISA with anti-CRP antibodies (Calbiochem,
San Diego, CA). The CRP assay was standardized and had
a sensitivity of 0.08 mg/mL [21].
Statistical analysis
The results are presented as mean ± SD or median with
interquartile range (IQ). Continuous variables were ana-
lyzed using a two-tailed student's t test for normally dis-
tributed variables; otherwise difference in median values
was assessed using nonparametric tests (Mann-Withney U
test for two groups of continuous data and the Kruskal-
Wallis test for three or more groups). For categorical vari-
ables, testing for difference in proportions was performed
using the Chi-square or the Fisher's exact test when indi-
cated. Pairwise correlation was performed using the Spear-
man rank correlation coefficient. Missing values for PSI
scores were encountered in less than 4% of the total pop-
ulation sample. Multiple imputations were used to assess
missing values [22]. Factors with p < 0.10 in our univari-
ate analysis were entered into a multiple logistic regres-
sion model. All potential explanatory variables included
in the multivariable analyses were subjected to correlation
matrix for analysis of collinearity. Variables with associa-
tion among each other were not included in the multivar-
iable model. Interactions were explored between the
variables retained in the multivariable models. Cumula-
tive-event curves were estimated with the Kaplan-Meier
method, and groups compared using the log-rank test. A
multivariate analysis of time to composite end point was
performed using Cox proportional hazards regression
model. Statistical significance was defined as p < 0.05.
Analyses were performed using StatView 5.0 (SAS Institute
Inc., Cary, NC) and SPSS 12.0 (SPSS Inc., Chicago, IL)
software.
Results
Characteristics of the study population
Three hundred one consecutive patients (mean age 73.9 ±
5.3 years) participated in the study. Sixty percent of the
participants were male. Thirty six percent had one major
comorbid illness and 51% had two or more. Chronic pul-
monary diseases (33%), diabetes mellitus (20%), and
congestive heart failure (10%) accounted for the majority
of chronic diseases. According to the PSI score on admis-
sion, 45% of patients were low-risk cases (class II-III),
41% were moderate risk (class IV), and 14%, high risk
(class V). The median age of patients in each class was 71
years (range 65 to 77) for class II, 72 years (range 65 to 89)
for class III, 74 years (range 67 to 91) for class IV, and 75
years (range 69 to 94) for class V. Thirty nine percent had
an abbreviated MMSE of 14 or lower while 61% scored 15
or higher. Figure 1 displays the baseline PSI scores, Charl-
son Index, abbreviated MMSE, serum TNF-α, and CRP lev-
els in function of PSI class categories. A significant
correlation was observed between PSI class severity andBMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
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each of the following variables: TNF-α (R = 0.29, 95%
confidence interval (CI) 0.18 to 0.4; p < 0.001) and Charl-
son Index R = 0.23, 95% CI 0.12 to 0.34; p < 0.001) but
not with CRP (R = 0.09, 95% CI-0.02 to 0.20; p = 0.11) or
abbreviated MMSE (R = -0.042, 95% CI-0.15 to 0.07; p =
0.46).
The composite end point of hospital readmission or death
was reached in 62 (21%) patients over the course of a one
year period. Thirteen patients were lost for follow up after
discharge. Thirty three patients were readmitted to a hos-
pital with a median time from discharge of 176 days
(range 17–341 days). None of the readmissions was con-
sidered an elective admission. The reasons for readmis-
sion included recurrence of pneumonia (n = 6),
cardiovascular events (n = 9), exacerbation of chronic pul-
monary disease (n = 11), and other acute conditions (n =
7). Case fatality rate was 10% at 12 months. The causes of
death reported were pneumonia (n = 4), ischemic heart
disease (n = 11), acute cerebrovascular accident (n = 5),
and chronic pulmonary obstructive disease (n = 7). In two
cases, the cause of death was not known.
Table 1 depicts the demographic characteristics of those
with favorable and unfavorable outcome. The two groups
were comparable in age, gender distribution, and smok-
ing history. However, a higher Charlson Index and a lower
cognitive and functional status were observed in those
with unfavorable outcome (p = 0.002, p = 0.006, and p =
0.01; respectively). The clinical presentation and radio-
graphic patterns of the study population are shown in
table 2. Although those with unfavorable outcome had a
higher PSI score, the distribution of patients by risk of
mortality was not significantly different between the two
groups. TNF-α and CRP levels were also comparable
between those with favorable and unfavorable outcomes.
Distribution of the Pneumonia Severity Index scores, theCharlson Index, the abbreviated MMSE, serum TNF-α, and CRP  according to PSI classes Figure 1
Distribution of the Pneumonia Severity Index scores, theCharlson Index, the abbreviated MMSE, serum TNF-α, and CRP 
according to PSI classes. Data are provided in box plot format (median, 25%–75%).BMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
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Two hundred seventeen (72%) participants received a
fluoroquinolone and 84 (28%) had a combination of a
third generation cephalosporin plus a macrolide. A fluor-
oquinolone was prescribed for 171 of patients with favo-
rable outcome compared to 46 for those with unfavorable
outcome (p = 0.8). The median time to initial hospital
antimicrobial therapy was comparable at one hour post
presentation to the emergency department for both
groups (range 1–3 hours; p = 0.9). Similarly, the duration
of hospitalization was not significantly different (6.8 ± 5.2
days for those in the favorable outcome and 7.5 ± 5.3 days
for those in the unfavorable outcome group, respectively;
p = 0.35). Home care services were set up for 22 patients
(13 and 9 for the favorable and unfavorable outcome
group, respectively) while discharge to a nursing home
occurred in 8 (5 and 3, respectively). None of the partici-
pants underwent rehabilitation during the period of the
study.
Microbiology
Two serial blood cultures (n = 292, 97%) and serology (n
= 253, 84%, acute illness single sample) were performed.
Table 1: Demographics characteristics of the study population
Favorable outcome (n = 239) Unfavorable outcome (n = 62) P value
Age, mean, years 72.6 ± 8.3 74.4 ± 6.7 0.08
Gender (Male/Female), n 144/95 36/26 0.8
Abbreviated MMSE 15.9 ± 3.3 14.2 ± 4.4 0.006
Preadmission ADL 7.7 ± 2.7 8.9 ± 3.4 0.01
Comorbidities, n (%)
Congestive heart failure 23 (10) 7 (11) 0.9
Chronic pulmonary diseases 76 (32) 23 (37) 0.5
Cerebrovascular accident 15 (6) 6 (10) 0.5
Diabetes mellitus 43 (18) 16 (26) 0.2
Charlson Index, n (%) 0.002
03 6  ( 1 5 ) 3  ( 5 )
1–2 147 (62) 33 (53)
3–4 51 (21) 20 (32)
≥5 5 (2) 6 (10)
Smoking status, n (%)
Currently smoking 21 (9) 9 (15) 0.3
Past smokers 82 (34) 25 (40) 0.4
Table 2: Clinical characteristics of the study population
Favorable outcome (n = 239) Unfavorable outcome (n = 62) P value
Symptoms, n (%)
Cough 153 (64) 37 (60) 0.6
Dyspnea 160 (67) 43 (69) 0.8
Chest pain 29 (12) 10 (16) 0.5
PSI score, mean ± SD 93.5 ± 27.7 104.3 ± 32.2 0.02
PSI Classes, n (%) 0.1
Class II 47 (20) 10 (16)
Class III 69 (29) 10 (16)
Class IV 92 (38) 30 (49)
Class V 31 (13) 12 (19)
Chest radiographs, n (%)
Multilobar disease 45 (19) 16 (26) 0.3
Bilateral disease 35 (15) 11 (18) 0.7
Pleural effusion 20 (8) 9 (15) 0.2
Inflammatory markers*
TNF-α, pg/ml 23.5 (15.4–31.3) 25.9 (16.9–3.8) 0.3
CRP, mg/L 101.4 (64.4–124.3) 113.2 (77.8–140.1) 0.1
*Expressed as median with interquartile rangeBMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
Page 6 of 10
(page number not for citation purposes)
A sputum sample was obtained in 235 (78%) patients but
culture was only performed in good quality samples (n =
141, 47%). Detection of the L. pneumophila (serotype 1)
urinary antigen by ELISA was performed in 265 (88%)
cases. Pleural fluid culture was carried out in 13 (4%)
cases.
Overall, 139 pathogens were detected, of which 82 (59%)
were detected by sputum examination and 57 (41%) were
detected by other techniques. S. pneumoniae constituted
47 of the 139 pathogens (34%), and was the most fre-
quent pathogen. Other pathogens included Hemophilus
influenzae (n = 25, 18%), Chlamydia pneumoniae (n = 20,
14%), Legionella pneumophila (n = 14, 10%), and Moraxella
catarrhalis (n = 9, 6%), respectively. The highest values for
TNF-α and CRP levels were observed in patients with
pneumonia caused by Streptococcus pneumoniae and
Legionella pneumophila (table 3). However, there were no
differences in serum TNF-α or CRP values when the differ-
ent etiologic groups were compared. Of interest, median
TNF-α but not CRP levels were significantly higher in
patients with microbiologically-confirmed pneumonia
(23.4 pg/ml IQ [17.9–31.5] and 114.1 mg/l IQ [71.4–
144.9]; respectively) compared to those with microbio-
logically-unconfirmed pneumonia (20.2 pg/ml IQ [10.8–
32.3] and 102.9 IQ [59.7–133.8]; respectively) (p = 0.002
and 0.08; respectively).
Risk factors for functional decline on discharge
A total of 108 (36%) out of 301 participants had a decline
in functional status on hospital discharge. As shown in
figure 2, higher risk categories were associated with higher
rates of functional decline at discharge (R = 0.26, 95% CI
0.15–0.36; p < 0.001). A significant association was also
detected between functional decline and serum TNF-α
levels (R = 0.46, 95% CI 0.36–0.54; p < 0.001), Charlson
Index (R = 0.24, 95% CI 0.14–0.35; p < 0.001), abbrevi-
ated MMSE (R = -0.15. 95% CI-0.26 to -0.037; p = 0.01)
and length of hospital stay (R = 0.27, 95% CI 0.17–0.38;
p < 0.001) but not with age or CRP levels.
In multivariate analysis, only serum TNF-α (odds ratio
[OR] 1.12, 95% CI 1.08–1.15; p < 0.001) and the Charl-
son Index (OR = 1.39, 95% CI 1.14 to 1.71; p = 0.001)
were independently associated with decline in functional
status at the time of hospital discharge.
Functional recovery
The change in ADL score at each successive follow-up
period is presented in figure 3. For the period ranging
from hospital discharge up to 30 days, the improvement
in ADL was the largest in all four risk categories. The
improvement was correlated with the PSI risk severity (p
= 0.03) as the largest change in ADL was noted in Class V.
From days 30 to 60, the absolute change in ADL was the
smallest in Class II but an improvement in function status
was still observed in the remaining risk classes. In compar-
ison, the third follow up period (60 to 90 days) showed
the smallest amount of change in terms of ADL improve-
ment across all classes. At the end of the follow-up period
of 90 days, 34 (12%) patients out of 290 remaining
Frequency plot of decline in functional status stratified by the  Pneumonia Severity Index classes (p < 0.001) Figure 2
Frequency plot of decline in functional status stratified by the 
Pneumonia Severity Index classes (p < 0.001).
Table 3: Microbial etiology and corresponding TNF-α and CRP levels
Microorganisms Definite (n) Probable (n) TNF-α (pg/ml)* CRP (mg/L)*
Streptococcus pneumoniae 16 36 49.8 (36.6–76.1) 127.3 (111.7–160.3)
Mycoplasma pneumoniae 2 - 16.9 (12.9–22.6) 56.6 (41.7–118.9)
Moraxella catarrhalis - 9 19.8 (14.7–26.0) 85.2 (55.0–123.9)
Chlamydia pneumoniae 20 - 21.1 (15.4–28.3) 98.7 (61.6–132.3)
Hemophilus influenzae - 25 23.2 (17.8–35.2) 103.5 (67.2–123.1)
Klebsiella pneumonia 1 7 28.7 (17.5–36.6) 122.4 (115.9–128.9)
Escherichia coli - 5 22.1 (18.4–25.9) 101.8 (64.7–145.7)
Legionella pneumophila 14 - 32.9 (26.5–55.1) 127.5 (106.8–176.3)
Influenza virus 4 - 18.2 (13.2–23.3) 76.6 (43.8–116.7)
*Expressed as median with interquartile rangeBMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
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showed persistent decline in functional status compared
to preadmission. In multivariate analysis, persistent
decline of functional status after 90 days of hospital dis-
charge was associated with abbreviated MMSE (OR 0.86;
95% CI 0.79–0.94; p = 0.001) and preadmission Charlson
Index (OR 1.28; 95% CI 1.04–1.59; p = 0.02) but not age,
PSI score, TNF-α, CRP levels, or microbial etiology.
Predictors of outcome
The lack of improvement in ADL was observed more fre-
quently in those with unfavorable outcome at all time
points (table 4). The probability of event-free survival was
significantly lower for patients who showed persistent
lack of functional recovery at day 90 post hospital dis-
charge (p < 0.001) than those who did not (figure 4). In a
Cox regression analysis, lack of recovery in functional sta-
tus at day 90 post discharge (Hazard Ratio (HR) 6.16,
95%CI 3.42–11.07; p < 0.001), abbreviated MMSE (HR
0.91; 95% CI 0.84–0.98), and the Charlson Index (HR
1.24, 95% CI 1.03–1.51; p = 0.025) were highly correlated
with hospital readmission or death. Neither age, TNF-α,
CRP nor PSI score was significantly associated with unfa-
vorable outcome.
Discussion
The physiologic changes associated with aging predispose
older patients to serious complications following hospi-
talization. In the current study, 36% and 11% of the
patients experienced functional impairment following
hospitalization for CAP and at 3 months post discharge.
These figures are consistent with those reported in the
Hospital Outcomes Project for the Elderly study which
showed that 1 in 3 elderly patients developed decline in
functional status after being hospitalized for an acute ill-
ness and about out 1 in 5 failed to recover after 3 months
[23]. Several risk factors of functional decline in older per-
sons have been described previously following acute ill-
ness including advanced age, previous impaired
functional status, and lower scores on the abbreviated
MMSE [15,24]. Other authors have found the presence of
bedsores and hypoalbuminemia as independent factors
of decline in ADL at the time of discharge but age and
comorbid diseases were not [25]. Our study expanded
those findings by showing a positive correlation between
serum TNF-α levels and functional decline irrespective of
demographic and clinical characteristics. The higher the
TNF-α levels were on admission, the higher was the risk of
decline in ADL. Torres and colleagues [26] identified a
similar relationship between PSI and functional decline in
hospitalized elderly patients with pneumonia. These asso-
ciations suggest that the severity of infection affected func-
tion in a dose-dependent response. Because TNF-α can act
directly on mature muscle to accelerate protein degrada-
tion [27], the loss of muscle mass following hospitaliza-
tion for CAP may contribute to significant weakness and
loss of mobility in the elderly which in turn would result
in functional decline.
Our data indicated a similar trend between CRP levels and
decline in ADL on discharge but the correlation was
weaker and did not reach statistical significance. The poor
association between functional status and CRP is high-
lighted by the conflicting observations in previously pub-
lished series where the relationship between CRP levels
and severity of illness in CAP has not been consistent
[28,29]. Seppa and colleagues [30] reported that CRP level
≥100 mg/L was a marker independently associated with
higher risk of death in patients with lower respiratory tract
infections. Additionally Hedlund [31] noted that those
patients with higher CRP levels had longer duration of
fever and hospital stay and had delayed clinical and radi-
ographic recovery on follow up after 8 weeks of discharge.
Yet, Vazquez and colleagues [28] found that CRP levels
were not correlated with PSI score. Although the CRP lev-
els in our study were higher in those with microbiologi-
cally established CAP, CRP is a non-specific marker of
inflammation and is subject to the influence of age, gen-
der, and comorbid conditions that may act as an impor-
tant stimulus for its hepatic synthesis.
Prior studies have pointed to an association between
increased length of hospital stay and decline in functional
status at the time of discharge [23,32]. In our cohort, 45%
of patients who remained hospitalized for more than 7
days developed functional decline compared to 32% who
were discharged within 7 days. Furthermore, the func-
tional decline continued further till 3 months after hospi-
Change in Activity of Daily Living score (mean ± SD) for each  of the Pneumonia Severity Index class at each successive fol- low-up period Figure 3
Change in Activity of Daily Living score (mean ± SD) for each 
of the Pneumonia Severity Index class at each successive fol-
low-up period.BMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
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tal discharge. However, in multivariate analysis, this
association lost its significance. The length of stay in our
model acts as a proxy for severity of illness and reflects the
consequences of deconditioning effect of bed rest and
iatrogenic complications [33].
In line with other investigations [34,35], we found that
the vast majority of newly disabled community-dwelling
older persons recovered independent function at day 90
post hospital discharge. Persons who were cognitively
impaired or severely burden with coexisting diseases were
less likely to recover and more likely to be hospitalized or
to succumb to their underlying diseases within one year of
hospital discharge for CAP. The Hospital Admission Risk
Profile Index (HARP) [15] that was developed to identify
older patients at risk for functional decline following
acute medical illness incorporated similar characteristics
to those found significant in our model: ADL and abbre-
viated MMSE. Unlike the HARP study, age was not an
independent factor in our study but the burden of comor-
bidities was. With the scarcity of resources, a future risk
stratification system based on these findings might be
proven helpful to target older patients who are likely to
benefit from interventional strategies.
Strengths of our study include the prospective design, the
homogeneity of our study population, the high reliability
and accuracy of prognostic indices, and the low rate of
attrition. While other studies [25,34] have addressed the
question of functional decline and recovery in the elderly
following an acute illness, we have limited our investiga-
tion to older patients with CAP after implementing an
approved CAP pathway. Because the nature of the under-
lying acute illness may impact the rate of recovery inde-
pendently [36], our findings would be more relevant
when evaluating long term management of older patients
with CAP. The present study also has its limitations that
warrant further discussion. First, the reliance on proxies'
report of ADL function at the time of admission as well
during the time of telephone interviews may have resulted
in inaccurate estimation of functional declines because of
the biases documented in other studies comparing car-
egiver reports of patient health with self-report informa-
tion [37,38]. However it is unlikely that this bias seriously
affected results because previous studies have shown that
surrogate bias is lowest for directly observable measures
[39]. Furthermore, excluding these patients would have
introduced selection bias that would have favored those
with less disease severity. Second, the acute illness may
have affected our baseline measurement of cognitive func-
tion. Unfortunately, no true criterion standard exists for
determining preexisting cognitive dysfunction [40]. Third,
the rate of readmission and death might have been under-
estimated if participants have moved out of state or
adopted different identification numbers. Fourth, our
study population was limited to a single hospital. Initial
processes of care and microbiological variation might not
be reproducible in other geographic areas and could limit
the generalization of our findings. However, our popula-
tion did reflect the demographic characteristics of persons
aged 65 years or older in Western New York, which are
comparable to the United States as a whole. Fifth, we have
not included an assessment of the socioeconomic status
of our study population. There have been conflicting
results concerning the relationship between socioeco-
nomic status and pneumonia in terms of both diagnosis
Kaplan-Meier plot of one year hospital readmission or death  by functional decline at day 90 post hospital discharge from  CAP Figure 4
Kaplan-Meier plot of one year hospital readmission or death 
by functional decline at day 90 post hospital discharge from 
CAP. Persistent functional decline at day 90 (broken line) 
versus recovery of functional status by day 90 (continuous 
line) (logrank test p < 0.001).
Table 4: Comparison of functional status at follow up time points to preadmission status
Functional status (ADL) Favorable outcome (n = 239) Unfavorable outcome (n = 62) P value
Compared to preadmission
Decline on discharge,n (%) 69 (29) 39 (63) <0.001
Decline at day 30, n (%) 39 (16) 36 (58) <0.001
Decline at day 60, n (%) 17 (7) 24 (39) <0.001
Decline at day 90, n (%) 14 (6) 20 (32) <0.001BMC Geriatrics 2006, 6:12 http://www.biomedcentral.com/1471-2318/6/12
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and outcome. Three studies [41-43] have reported an
increased relative risk for lower social class quintiles and
pneumonia and bronchitis mortality. Other studies, look-
ing at pneumonia diagnosis and SES found no relation
between the two [44,45]. We should point out that we
have not assessed the processes of post hospital care that
may have contributed to prolonged functional disability
in susceptible patients. This factor should be taken into
consideration when interpreting the results of our study.
Conclusion
Based on the results of this study, older persons hospital-
ized for CAP may be at increased risk of functional loss
both at the time of, and after discharge. TNF-α could be
partially responsible for the severity of functional decline
and may be useful to identify patients at risk. Functional
recovery may be correlated with PSI class severity. Absence
of functional improvement after 90 days of hospital dis-
charge appears to be a strong predictor of hospital
readmission and mortality. Further research is needed on
the complex interaction between biological markers and
recovery of functional status.
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